Sciegen Pharmaceuticals
UEI: WH8BR7NRXLC5
• CAGE: 8NLP1
Overview
Parent Awardee
Keywords
Generic Pharmaceuticals Manufacturer
Name
Sciegen Pharmaceuticals
Website
Headquarters
Hauppauge, NY
United States
United States
Federal recipient
SCIEGEN PHARMACEUTICALS INC
(UEI WH8BR7NRXLC5, CAGE 8NLP1)
is headquartered in Hauppauge NY.
Its primary registered NAICS is 325412 Pharmaceutical Preparation Manufacturing.
The corporation
was founded in September 2009 and
federally registered in
July 2020.
Federal Registration and Certifications
Legal Name
SCIEGEN PHARMACEUTICALS INC
UEI
WH8BR7NRXLC5
CAGE Code
8NLP1
Primary NAICS
SBA Certifications
None
Self Certifications
Minority Owned Business
Self-Certified Small Disadvantaged Business
Subcontinent Asian (Asian-Indian) American Owned
Self-Certified Small Disadvantaged Business
Subcontinent Asian (Asian-Indian) American Owned
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Sept. 28, 2009
Initial Registration
July 17, 2020
Last Registration
Nov. 27, 2024
Registration Activation
Nov. 27, 2024
Registration Expiration
Nov. 25, 2025
Fiscal Year End
September 30
Reported Entity Types
For Profit Organization
Manufacturer of Goods
Manufacturer of Goods
State of Incorporation
NY
Country of Incorporation
USA
Employees
751-1000
Disaster Registry
Nationwide
Reported NAICS
Accepts Credit Cards
No